Joon Min Jung, MD; Keon Hee Lee, MD; Ye-Jee Kim, PhD; et al.
free access
JAMA Dermatol. 2020;156(8):844-853. doi:10.1001/jamadermatol.2020.1422
This population-based study examines the prevalence of cancer in patients with hidradenitis suppurativa.
Laetitia Penso, MSc; Mathilde Touvier, PhD; Mélanie Deschasaux, PhD; et al.
free access
JAMA Dermatol. 2020;156(8):854-862. doi:10.1001/jamadermatol.2020.1602
This cross-sectional study examines the dietary patterns of adults with current acne.
Jonathan I. Silverberg, MD, PhD, MPH; Eric L. Simpson, MD; Jacob P. Thyssen, MD; et al.
open access
JAMA Dermatol. 2020;156(8):863-873. doi:10.1001/jamadermatol.2020.1406
This randomized clinical trial investigates the efficacy and safety of abrocitinib in adolescents and adults with moderate-to-severe atopic dermatitis.
Melissa R. Laughter, PhD; Mayra B. C. Maymone, MD, DSc; Chante Karimkhani, MD; et al.
free access
JAMA Dermatol. 2020;156(8):874-881. doi:10.1001/jamadermatol.2020.1573
This cohort study reports the trends and variations in skin and subcutaneous diseases, along with malignant melanoma and keratinocyte carcinoma, in the 50 states and the District of Columbia for the past 3 decades.
Cristian Navarrete-Dechent, MD; Konstantinos Liopyris, MD; Ayelet Rishpon, MD; et al.
free access
JAMA Dermatol. 2020;156(8):882-890. doi:10.1001/jamadermatol.2020.1450
This case-control study assesses multiple aggregated yellow-white globules as a diagnostic feature for basal cell carcinoma.
Sian-De Liu, BS; Wei-Ti Chen, MD, MS; Ching-Chi Chi, MD, MMS, DPhil
free access
JAMA Dermatol. 2020;156(8):891-900. doi:10.1001/jamadermatol.2020.1587
This systematic review and meta-analysis assesses the association of the use of certain classes of medications among patients and the development of bullous pemphigoid.
Scott A. Elman, MD; Cara Joyce, PhD; Kara Braudis, MD; et al.
free access
JAMA Dermatol. 2020;156(8):901-906. doi:10.1001/jamadermatol.2020.1698
This diagnostic study uses 12 previously defined candidate criteria items to create and validate classification criteria for discoid lupus erythematosus in an international set of patients from academic dermatology centers.